1990 (v1)
Publication
No description
Uploaded on: March 31, 2023
-
-
2014 (v1)Publication
In patients with relapsing-remitting MS (RRMS) fingolimod prevents disease relapses and delays disability progression. First dose administration of fingolimod is associated with a transient, dose-dependent decrease in heart rate (HR) in the 6 hours after drug intake.The aim of the study is to to assess safety and tolerability of the first dose...
Uploaded on: April 14, 2023